Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-03-14

FDA Approved: METHYLPHENIDATE — Original Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a generic methylphenidate product (Original Application) from Mylan Pharmaceuticals Inc., for conditions such as ADHD and narcolepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methylphenidate (Methylphenidate)

Snippet

ORIG AP for METHYLPHENIDATE (METHYLPHENIDATE)